Roche Holding AG's Headquarters As Drugmaker Acquires InterMune Inc. For $8.3 Billion

A Roche logo sits on a sign outside Roche Holding AG's headquarters in Basel, Switzerland, on Tuesday, Aug. 26, 2014. Roche, the world's largest maker of cancer drugs, is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune Inc. for $8.3 billion in cash. Photographer: Philipp Schmidli/Bloomberg via Getty Images
A Roche logo sits on a sign outside Roche Holding AG's headquarters in Basel, Switzerland, on Tuesday, Aug. 26, 2014. Roche, the world's largest maker of cancer drugs, is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune Inc. for $8.3 billion in cash. Photographer: Philipp Schmidli/Bloomberg via Getty Images
Roche Holding AG's Headquarters As Drugmaker Acquires InterMune Inc. For $8.3 Billion
ACHETER UNE LICENCE
Comment puis-je utiliser cette image ?
475,00 €
EUR

INFORMATIONS

Restrictions :
Contactez votre agence locale pour toute utilisation commerciale ou promotionnelle.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédits :
Bloomberg / Contributeur
Editorial - n° :
454204692
Collection :
Bloomberg
Date de création :
26 août 2014
Date de chargement :
Type de licence :
Infos autorisations :
Autorisation non disponible. Plus d'infos
Source :
Bloomberg
Référence :
SWISS ROCHE INTERMUNE
Taille max. de fichier :
4000 x 2667 px (33,87 x 22,58 cm) - 300 dpi - 2 MB